LIVN ($LIVN) Insider Trading & Smart Money Activity
$LIVN has 18 insider trades and 1 analyst rating on file. Insiders filed 18 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 1
LIVN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LIVN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Keybanc | Reiterates to buy | PT $92 | +5.5% | -0.6% | Read | |||||
| Insider | Donald Zurbay | Sell (Tax withholding) | 308 sh | $24.55K | -1.2% | -0.4% | — | ||||
| Insider | Donald Zurbay | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | Read | |||||
| Insider | Peter Wilver | Sell (Option exercise) | 4.04K sh | -1.2% | -0.4% | Read | |||||
| Insider | Ahmet TezelChief Innovation Officer | Buy (Option exercise) | 2.96K sh | -1.2% | -0.4% | — | |||||
| Insider | Ahmet TezelChief Innovation Officer | Buy (Option exercise) | 2.96K sh | -1.2% | -0.4% | Read | |||||
| Insider | Brooke Story | Sell (Option exercise) | 4.04K sh | -1.2% | -0.4% | — | |||||
| Insider | Todd Schermerhorn | Sell (Tax withholding) | 486 sh | $38.73K | -1.2% | -0.4% | Read | ||||
| Insider | Todd Schermerhorn | Buy (Option exercise) | 4.04K sh | -1.2% | -0.4% | — | |||||
| Insider | Susan Podlogar | Sell (Option exercise) | 4.04K sh | -1.2% | -0.4% | — | |||||
| Insider | William Kozy | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | — | |||||
| Insider | Enxing Seng Stacy | Sell (Option exercise) | 4.04K sh | -1.2% | -0.4% | — | |||||
| Insider | Enxing Seng Stacy | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | — | |||||
| Insider | Enxing Seng Stacy | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | Read | |||||
| Insider | Francesco Bianchi | Sell (Option exercise) | 4.04K sh | -1.2% | -0.4% | — | |||||
| Insider | Francesco Bianchi | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | — | |||||
| Insider | Francesco Bianchi | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | Read | |||||
| Insider | Barry James Christopher | Sell (Tax withholding) | 486 sh | $38.73K | -1.2% | -0.4% | — | ||||
| Insider | Barry James Christopher | Buy (Grant or award) | 2.38K sh | -1.2% | -0.4% | Read |
1W / 1M / 6M = how LIVN moved from the trade or filing date.
Insider trading in LIVN: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Enxing Seng Stacy | 3 | — | Jun 15, 2026 | ||
| Francesco Bianchi | 3 | — | Jun 15, 2026 | ||
| Donald Zurbay | 2 | — | Jun 15, 2026 | ||
| Ahmet Tezel | Chief Innovation Officer | 2 | — | Jun 15, 2026 | |
| Todd Schermerhorn | 2 | — | Jun 15, 2026 | ||
| Barry James Christopher | 2 | — | Jun 15, 2026 | ||
| Peter Wilver | 1 | — | Jun 15, 2026 | ||
| Brooke Story | 1 | — | Jun 15, 2026 | ||
| Susan Podlogar | 1 | — | Jun 15, 2026 | ||
| William Kozy | 1 | — | Jun 15, 2026 |
Analyst ratings on LIVN
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Keybanc | Reiterates | buy | $92 | +5.5% | -0.6% | Read |
Frequently asked questions
What is the latest insider trade in LIVN?
Donald Zurbay filed a sell (tax withholding) of 308 sh worth $24.55K on Jun 15, 2026.
Other medical devices stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.